SUPREME COURT SEEKS ADMINISTRATION'S OPINION ON IDE APPROVAL PREEMPTION OVER TORT CLAIMS; IOLAB PETITION QUESTIONS APPLICABILITY OF MEDTRONIC V. LOHR
This article was originally published in The Gray Sheet
Executive Summary
The Administration is expected to file in 60-90 days its opinion on whether FDA's Investigational Device Exemption regulation preempts state tort claims in response to a case before the U.S. Supreme Court.
You may also be interested in...
Supreme Court Seeks Solicitor General’s Input On PMA Preemption
The U.S. Supreme Court is considering whether to hear a potentially far-reaching case on whether patients injured by PMA-approved devices can sue manufacturers under state laws
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”